Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)